These are additional notices applicable to this website.
37747 – Identification and use of novel adipokines for reduction of visceral fat using thermogenesis. The Need Obesity as a result of an increase in intra-abdominal (or visceral) fat is an independent risk factor for major diseases such as type 2 diabetes and cardiovascular diseases. Risk is increased with higher levels of intra-abdominal fat due to increases in insulin resistance and chronic... Read More
14970 – Novel engineered probiotic that competes specifically with the pathogen Salmonella for vital nutrients in the inflamed intestine of humans and livestock to prevent or treat infection. Salmonella is a genus of bacteria that is a major cause of foodborne illness throughout the world. The illness usually lasts 4-7 days, and most people recover without treatment. However, in the very young... Read More